The Q2 earnings report for Champions Oncology CSBR was released on Wednesday, December 11, 2024 at 04:00 PM.
Here’s what investors need to know about the latest announcement.
Earnings
Champions Oncology beat estimated earnings by 400.0%, reporting an EPS of $0.05 versus an estimate of $0.01.
Revenue was up $1.92 million from the same period last year.
Analysis of Past Earnings
During the previous quarter, the company beat on EPS by $0.14, leading to a 10.0% increase share price change the next day.
Here’s a look at Champions Oncology’s past performance:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.16 | -0.15 | -0.17 |
| EPS Actual | 0.11 | 0.01 | -0.16 | -0.15 |
| Revenue Estimate | 13.23M | 12.69M | 13.48M | 12.84M |
| Revenue Actual | 14.06M | 14.00M | 12.02M | 11.57M |
To track all earnings releases for Champions Oncology visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
